Who
Eduardo Guarita Bezerra
EVP & Chief Financial Officer
Company insider
Files Form 4 as: EVP & Chief Financial Officer, Perrigo Company; SVP and CFO, Del Monte.
In numbers
- Trades disclosed
- 112
- Buys
- 2
- Sells
- 8
- Bought
- $214K
- Sold
- $168K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 25 Mar 2019
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —141,376 | filing |
| 8 Jul 2026filed 10 Jul 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —141,376 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $99K9,175 at $10.83 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $24K2,235 at $10.83 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,175 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,175 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $99K9,175 at $10.83 | filing |
| 5 Jun 2026filed 8 Jun 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $24K2,235 at $10.83 | filing |
| 13 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,678 | filing |
| 13 May 2026filed 15 May 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,678 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $69K6,369 at $10.85 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $17K1,551 at $10.85 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,369 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,369 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $69K6,369 at $10.85 | filing |
| 2 Apr 2026filed 3 Apr 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $17K1,551 at $10.85 | filing |
| 6 Mar 2026filed 10 Mar 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $52K4,870 at $10.72 | filing |
| 6 Mar 2026filed 10 Mar 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code F | $13K1,186 at $10.72 | filing |
| 6 Mar 2026filed 10 Mar 2026 | PRGO Perrigo CompanyBiotechnology | SEC FORM 4 Code M | $53K4,980 at $10.72 | filing |
| 6 Mar 2026filed 10 Mar 2026 | PRGO Perrigo Companyoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,870 | filing |
News
Ovid Therapeutics (NASDAQ:OVID) and Perrigo (NYSE:PRGO) Head to Head ReviewPRGO · themarketsdaily.com · 20 Oct 2026Sleepy Eye to sell former Del Monte plantDMC · nujournal.com · 15 Oct 2026Shanxi, paesaggio pittoresto autunnale del monte LuyaDMC · italian.cri.cn · 14 Oct 2026Contrasting Neurocrine Biosciences (NASDAQ:NBIX) and Perrigo (NYSE:PRGO)PRGO · dailypolitical.com · 10 Oct 2026[Vantage Point] Is Del Monte in default? The debt behind the labelDMC · rappler.com · 7 Oct 2026
0 headlines in the last 90 days name Eduardo Guarita Bezerra; 5 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.